Scilex Holding Company
SCLX
$6.81
-$0.09-1.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -46.54% | -26.82% | -12.98% | 7.79% | 21.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -46.54% | -26.82% | -12.98% | 7.79% | 21.07% |
| Cost of Revenue | -36.49% | -23.26% | -18.76% | -10.65% | 6.43% |
| Gross Profit | -50.74% | -28.34% | -10.29% | 17.23% | 28.46% |
| SG&A Expenses | 124.24% | 154.02% | -4.06% | -2.01% | -0.52% |
| Depreciation & Amortization | 8.26% | -0.62% | -1.67% | -2.44% | -1.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.55% | 120.13% | -4.42% | -5.44% | -1.84% |
| Operating Income | -193.47% | -218.07% | 0.03% | 11.30% | 11.99% |
| Income Before Tax | -413.72% | -281.12% | 31.90% | 30.98% | 36.31% |
| Income Tax Expenses | 2,700.00% | 137.50% | 125.00% | -120.00% | -107.69% |
| Earnings from Continuing Operations | -413.76% | -281.10% | 31.89% | 30.98% | 36.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -392.72% | -278.45% | 33.35% | 30.98% | 36.32% |
| EBIT | -193.47% | -218.07% | 0.03% | 11.30% | 11.99% |
| EBITDA | -201.64% | -229.42% | -0.06% | 11.63% | 12.38% |
| EPS Basic | -110.06% | -32.17% | 77.02% | 75.89% | 61.66% |
| Normalized Basic EPS | -41.53% | -12.60% | 81.53% | 69.21% | 40.69% |
| EPS Diluted | -105.80% | -33.64% | 76.24% | 75.09% | 60.94% |
| Normalized Diluted EPS | -41.53% | -12.60% | 81.53% | 69.21% | 40.69% |
| Average Basic Shares Outstanding | 10.21% | 227.26% | 279.40% | 253.55% | 168.91% |
| Average Diluted Shares Outstanding | 10.21% | 227.26% | 279.40% | 253.55% | 168.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |